Tylenol maker: possible FDA label change 'unsupported by scientific evidence'

Tylenol maker Kenvue is calling on the Food and Drug Administration to back off a proposed safety label change to acetaminophen after the Trump administration linked its use during pregnancy to autism. In response to a citizen petition filed last month, the company said the “expansive scientific evidence developed over many years” does not support a causal link between acetaminophen use in pregnancy and developmental disorders. ...